ALT - Altimmune, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue10,738.3223,236.1754,654.4685,548.203
Cost of Revenue18,406.3297,221.465,063.654,265.07
Gross Profit-7,668.007-3,985.285-409.1821,283.133
Operating Expenses
Research Development----
Selling General and Administrative6,945.1346,435.134,880.9831,181.294
Non Recurring----
Others----
Total Operating Expenses25,351.46313,656.599,944.6335,446.364
Operating Income or Loss-14,613.141-10,420.415-5,290.165101.839
Income from Continuing Operations
Total Other Income/Expenses Net-37,450.624-666.397-1,358.737-59.572
Earnings Before Interest and Taxes-14,613.141-10,420.415-5,290.165101.839
Interest Expense-162.139-38.499-55.305-58.572
Income Before Tax-52,063.765-11,086.812-6,648.90242.267
Income Tax Expense-5,638.375---
Minority Interest----
Net Income From Continuing Ops-46,425.39-11,086.812-6,648.90242.267
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-46,425.39-11,086.812-6,648.90242.267
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-51,355.4-11,455.36-6,787.457-593.896